🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators aimed to confirm the efficacy and safety of transdermal p...
Status
Completed
Location
Gangdong Sacred Heart Hospital, Hallym Univ
Start Date
2016-12-02
Trial ID
NCT03153735
Treatments Being Tested
This study will evaluate the safety and efficacy of OPTIVE FUSION™ compared...
Status
Completed
Location
Multiple Locations
Start Date
2014-05-14
Trial ID
NCT02117687
Treatments Being Tested
The effect of Kynex versus Refresh Plus in subjects with mild to moderate d...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00809198
Treatments Being Tested
This study will evaluate the safety and efficacy of OPTIVE® MD for ocular s...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00987727
To compare the efficacy and safety of two non-preserved artificial tears, (...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00938704
Treatments Being Tested
Seprafilm is an FDA-approved temporary bioresorbable barrier that physicall...
Status
Terminated
Location
Weill Medical College of Cornell University
Start Date
2012-05
Trial ID
NCT01632202
Treatments Being Tested
Clinical post-marketing quasi-experimental before-and-after trial to determ...
Status
Completed
Location
Hospital Universitario Araba
Start Date
2021-02-17
Trial ID
NCT06731725
Treatments Being Tested
This is a comparative, open label, parallel group, non interventional study...
Status
Unknown
Location
Tanta University
Start Date
2022-01-01
Trial ID
NCT05313425
Treatments Being Tested
To compare the effects of hydroxypropyl guar (HPG)/hyaluronic acid (HA)- an...
Status
Completed
Location
Keelung Chang Gung Memorial Hospital
Start Date
2021-12-07
Trial ID
NCT06221345
In patients with moderate to severe dry eye syndrome, the test drug (HA 0.1...
Status
Completed
Location
Taejoon Pharmaceutical Co., Ltd.
Start Date
2019-11-12
Trial ID
NCT04127851